GLOW Blend 70mg (GHK-Cu, TB-500, BPC-157), Research Peptide Canada

Buy the GLOW blend in Canada from Anglo Peptides, a Canadian research-grade combination of GHK-Cu, TB-500 and BPC-157 in a single vial. Every vial is produced in a cGMP-compliant facility, independently verified by third-party HPLC, and lyophilised for stability. Orders ship same-day in cold-pack packaging, arrive within 1 to 3 business days across Canada, and include a batch-specific certificate of analysis. The summary below reflects the published preclinical literature on the individual components and is provided for laboratory research context only.

What Is the GLOW Blend?

GLOW is a research blend that combines three of the most-studied tissue-repair and skin-research peptides in one lyophilised vial: 50 mg of GHK-Cu, 10 mg of TB-500 (thymosin beta-4 fragment) and 10 mg of BPC-157, for 70 mg of total peptide content. The combination is used in research settings that examine connective-tissue, dermal and wound-repair pathways, where the three peptides act through complementary mechanisms. Each component is individually characterised in the literature, and Anglo Peptides also offers them as standalone products for researchers who prefer to dose them separately.

Components and Their Mechanisms

GHK-Cu (50 mg). A naturally occurring copper-binding tripeptide (Gly-His-Lys) that delivers bioavailable copper and stimulates collagen, glycosaminoglycan and proteoglycan synthesis and extracellular-matrix remodelling in fibroblast and wound models.^[1][2]

TB-500 (10 mg). A synthetic fragment related to thymosin beta-4, the major actin-sequestering protein in cells, which acts extracellularly as a repair signal after injury and has accelerated re-epithelialisation, collagen deposition and angiogenesis in dermal wound models.^[3][4]

BPC-157 (10 mg). A stable gastric pentadecapeptide that promotes angiogenesis through the VEGFR2 and nitric-oxide systems and supports tendon, muscle and soft-tissue healing in animal models.^[5][6]

The research rationale for combining them is that they target repair through distinct but overlapping routes: copper-dependent matrix synthesis (GHK-Cu), actin-driven cell migration and re-epithelialisation (TB-500), and angiogenesis and cytoprotection (BPC-157).

Research Applications

The GLOW combination is studied in the context of skin, connective-tissue and wound-repair research, drawing on the individual evidence base of each peptide. All of that evidence is preclinical, from cell-culture and animal models, and none of the three components is an approved therapeutic. The blend is supplied for laboratory research use only, and there are no human clinical trials of this specific three-peptide combination.

Stability, Solubility and Handling

Anglo Peptides supplies GLOW as a single lyophilised powder containing all three peptides. For research it is reconstituted with sterile or bacteriostatic water. As GHK-Cu is a copper complex, avoid combining the reconstituted solution with strong chelators or high concentrations of reducing agents that could dissociate the copper. Store the lyophilised powder cold, dark and desiccated, with long-term storage at -20°C; keep reconstituted solution refrigerated and use within a few weeks, avoiding repeated freeze-thaw cycles. These notes apply to in-vitro and animal research only.

Product Specifications

• Compound: GLOW blend (GHK-Cu + TB-500 + BPC-157)
• Composition: GHK-Cu 50 mg, TB-500 10 mg, BPC-157 10 mg
• Total peptide content: 70 mg per vial
• Purity: Components ≥99% by HPLC
• Form: Lyophilised powder
• Testing: Independent third-party HPLC and mass spectrometry
• Documentation: Batch-specific certificate of analysis
• Origin: Made in Canada

Quality, Testing and Canadian Sourcing

Every batch of the Anglo Peptides GLOW blend is independently tested with a lot-specific certificate of analysis. Producing and finishing vials in Canada lets us verify the full labelled content of each component and ship quickly without customs delays. Read more on our Canadian sourcing page. The individual components are available as GHK-Cu, TB-500 and BPC-157, and a four-peptide version that adds KPV is offered as the KLOW blend.

Why a Combined Blend

The rationale for delivering GHK-Cu, TB-500 and BPC-157 in a single vial is that the three peptides are studied for tissue-repair effects through mechanisms that do not overlap completely. GHK-Cu research centres on copper-dependent collagen and extracellular-matrix synthesis; TB-500 research centres on actin regulation, cell migration and re-epithelialisation; and BPC-157 research centres on angiogenesis through the VEGFR2 and nitric-oxide systems together with broad cytoprotection. A combined preparation lets researchers examine these complementary routes together and simplifies handling when a protocol calls for all three. It is important to be clear that combining them is a formulation and convenience decision, not an independently validated intervention: there are no human clinical trials of this specific three-peptide blend, and the supporting evidence is the preclinical literature of each individual component. Researchers who need to isolate the contribution of any single peptide should use the standalone products instead.

Considerations for Research Use

The main analytical caveat with any blend is attribution: when three active peptides are present together, an observed effect cannot be assigned to one component without comparison against the peptides administered individually, so a well-designed study using GLOW will typically include single-peptide and vehicle controls. The copper content of GHK-Cu adds the handling constraints noted above. Because the vial contains a fixed ratio of the three peptides, dose-response work is constrained to that ratio unless the components are sourced separately. As always, confirmation of identity and verification of purity for each component lot are essential, and an under-dosed or copper-depleted preparation will distort results. Every Anglo Peptides batch ships with third-party testing and a lot-specific certificate of analysis.

Reconstitution, Storage and Handling in Detail

For laboratory use, the lyophilised powder is brought to room temperature before opening to avoid condensation, then reconstituted by adding sterile or bacteriostatic water slowly down the inside wall of the vial rather than directly onto the powder, and swirled gently rather than shaken. Because the blend contains the copper peptide GHK-Cu, avoid combining the reconstituted solution with strong chelators such as EDTA or high concentrations of reducing agents such as ascorbic acid, which can dissociate the copper and change what is being studied. Once reconstituted, keep the solution refrigerated at 2 to 8 degrees Celsius, protected from light, and use it within a defined window, aliquoting into single-use portions to avoid the repeated freeze-thaw cycles that degrade peptides. The lyophilised powder is more stable than solution and is best stored frozen, sealed and desiccated, for long-term holding. These are general research-handling conventions; the lot-specific certificate of analysis should always take precedence.

Frequently Asked Questions

References

1. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. PubMed
2. Maquart FX, Pickart L, Laurent M, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988;238(2):343-346. DOI
3. Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005;11(9):421-429. PubMed
4. Malinda KM, Sidhu GS, Mani H, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368. PubMed
5. Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011;110(3):774-780. PubMed
6. Sikiric P, et al. Stable gastric pentadecapeptide BPC 157-NO-system relation. Curr Pharm Des. 2014;20(7):1126-1135. PubMed

Research use only. The GLOW blend supplied by Anglo Peptides is intended exclusively for licensed laboratory and academic research. It is not a drug, dietary supplement, cosmetic, or medical product, and is not for human consumption, diagnosis, or treatment.

Researchers who buy GLOW blend from Anglo Peptides receive a vial verified to ≥99% purity, batch-tested by Janoshik Labs, and shipped from within Canada. Choose the 70mg size above.